Miao YR, Thakkar KN, Qian J, Kariolis, MS, Wei H, Nandagopal S, Yang T, Diep Anh, Cherf GM, Xu Y, Moon EJ, Xiao Y, Alemany H, Li T, Yu W, Wei B, Rankin E, Giaccia, AJ. Clin Can Res 2021 (Accepted for Publication)
Neutralization of PD-L2 is essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer.
Aug 1, 2021
Neutralization of PD-L2 is essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer.
Miao YR, Thakkar KN, Qian J, Kariolis, MS, Wei H, Nandagopal S, Yang T, Diep Anh, Cherf GM, Xu Y, Moon EJ, Xiao Y, Alemany H, Li T, Yu W, Wei B, Rankin E, Giaccia, AJ. Clin Can Res 2021 (Accepted for Publication)
